SOUTH SAN FRANCISCO, Calif., April 09, 2024 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in.
Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024 lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Pan American Silver to Announce First Quarter 2024 Unaudited Results and Host Annual General and Special Meeting of Shareholders on May 8 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Pan American Silver Corp. will announce its unaudited results for the first quarter of 2024 after market close on Wednesday, May 8, 2024. Pan American will also be holding its Annual General and Special Meeting of shareholders the same day at 3:00 pm. - Veroeffentlicht am 09.04.2024
BIRMINGHAM, AL / ACCESSWIRE / April 8, 2024 / Diversified Energy Company PLC (LSE:DEC)(NYSE:DEC) ("Diversified" or the "Company") announces plans for members of its management team to participate in the